Debates
India’s Ashwagandha Leaf Ban Sparks Debate Over Safety, Science, and Supply Chain
The Government of India's directive banning ashwagandha leaves is igniting debate across the nutraceutical industry, pitting traditional use, modern science, and global supply chains against each other.
Read More







